alphaveWINDLAS₹1,135.00

Windlas Biotech Limited

₹ CrorePeersHESTERBIO INDOCO SAIPARENT SYNCOMF PANACEABIO NGLFINE HIKAL JAGSNPHARMMcap ₹2,396 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Non-current Assets
+ Property, Plant & Equipment	169.5	195.5	187.2
+ Capital Work-in-Progress	5.7	3.2	56.2
+ Other Intangibles	9.6	27.9	26.1
+ Intangibles under Development	0.0	2.1	3.4
+ Other Non-current Financial Assets	4.3	4.3	6.3
Non-current Financial Assets	4.3	4.3	6.3
+ Deferred Tax Assets	0.6	0.3	0.4
+ Other Non-current Assets	5.3	2.1	0.9
Total Non-current Assets	194.9	235.3	280.5
Current Assets
+ Inventories	62.2	81.4	61.8
+ Current Investments	173.4	223.4	268.4
+ Trade Receivables	136.3	166.9	227.4
+ Cash & Cash Equivalents	5.3	0.4	0.5
+ Other Bank Balances	25.7	15.5	1.3
+ Other Current Financial Assets	1.5	1.0	9.6
Current Financial Assets	342.2	407.2	507.2
+ Other Current Assets	26.2	33.3	57.8
Total Current Assets	431.3	525.1	626.9
Total Assets	626.2	760.5	907.3
Equity
+ Equity Share Capital	10.4	10.5	10.6
+ Other Equity / Reserves	439.5	495.3	570.3
Equity — Owners of Parent	449.9	505.8	580.8
Total Equity	449.9	505.8	580.8
Liabilities
+ Other Non-current Financial Liab	2.2	2.4	2.2
Non-current Financial Liabilities	2.2	2.4	2.2
+ Provisions — Non-current	2.3	2.9	3.3
Non-current Liabilities	4.5	5.2	5.6
+ Borrowings — Current	0.1	27.1	29.9
+ Trade Payables	131.5	167.2	238.5
+ Other Current Financial Liab	34.7	40.8	43.3
Current Financial Liabilities	166.4	235.1	311.7
+ Provisions — Current	0.7	1.6	1.8
+ Current Tax Liabilities	0.0	0.0	2.3
+ Other Current Liabilities	4.7	12.8	5.1
Current Liabilities	171.8	249.4	320.9
Total Liabilities	176.3	254.7	326.5
Total Equity & Liabilities	626.2	760.5	907.3
Assets — additional as-filed lines
+ Current Tax Assets	0.7	3.3	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	12.0	26.3
+ Dues to Other Creditors — Current	—	155.2	212.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.